Maintenance Rituximab after high-dose therapy and autologous stem cell transplantation in mantle cell lymphoma
Abstract: Mantle cell lymphoma (MCL) is an aggressive B cell lymphoma characterized by early dissemination and an unfavorable clinical course. Treatment with conventional chemotherapy resulted in unsatisfactory outcomes and a median survival of less than 3 years after diagnosis of MCL [1]. In recent...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
November 2017
|
| In: |
Biology of blood and marrow transplantation
Year: 2017, Jahrgang: 23, Heft: 11, Pages: 1811-1812 |
| ISSN: | 1523-6536 |
| DOI: | 10.1016/j.bbmt.2017.09.008 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1016/j.bbmt.2017.09.008 Verlag, Volltext: http://www.bbmt.org/article/S1083-8791(17)30716-4/abstract 
|
| Verfasserangaben: | Tobias Roider, Sascha Dietrich |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 157189134X | ||
| 003 | DE-627 | ||
| 005 | 20220814111433.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180410s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bbmt.2017.09.008 |2 doi | |
| 035 | |a (DE-627)157189134X | ||
| 035 | |a (DE-576)50189134X | ||
| 035 | |a (DE-599)BSZ50189134X | ||
| 035 | |a (OCoLC)1341001951 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Roider, Tobias |d 1988- |e VerfasserIn |0 (DE-588)112919017X |0 (DE-627)883826232 |0 (DE-576)486252264 |4 aut | |
| 245 | 1 | 0 | |a Maintenance Rituximab after high-dose therapy and autologous stem cell transplantation in mantle cell lymphoma |c Tobias Roider, Sascha Dietrich |
| 264 | 1 | |c November 2017 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 10.04.2018 | ||
| 520 | |a Abstract: Mantle cell lymphoma (MCL) is an aggressive B cell lymphoma characterized by early dissemination and an unfavorable clinical course. Treatment with conventional chemotherapy resulted in unsatisfactory outcomes and a median survival of less than 3 years after diagnosis of MCL [1]. In recent years, the prognosis of patients with MCL has improved considerably, and the refinement of dose-intensified approaches such as autologous stem-cell transplantation (ASCT) has contributed significantly to this development. | ||
| 650 | 4 | |a Autologous stem-cell transplantation | |
| 650 | 4 | |a High-dose chemotherapy | |
| 650 | 4 | |a Maintenance rituximab | |
| 650 | 4 | |a Mantle cell lymphoma | |
| 700 | 1 | |a Dietrich, Sascha |d 1979- |e VerfasserIn |0 (DE-588)136406300 |0 (DE-627)694354635 |0 (DE-576)301003408 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biology of blood and marrow transplantation |d [Erscheinungsort nicht ermittelbar] : Elsevier Health Sciences, 1998 |g 23(2017), 11, Seite 1811-1812 |h Online-Ressource |w (DE-627)334374782 |w (DE-600)2057605-5 |w (DE-576)118352229 |x 1523-6536 |7 nnas |a Maintenance Rituximab after high-dose therapy and autologous stem cell transplantation in mantle cell lymphoma |
| 773 | 1 | 8 | |g volume:23 |g year:2017 |g number:11 |g pages:1811-1812 |g extent:2 |a Maintenance Rituximab after high-dose therapy and autologous stem cell transplantation in mantle cell lymphoma |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bbmt.2017.09.008 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.bbmt.org/article/S1083-8791(17)30716-4/abstract |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180410 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 136406300 |a Dietrich, Sascha |m 136406300:Dietrich, Sascha |d 910000 |d 910100 |e 910000PD136406300 |e 910100PD136406300 |k 0/910000/ |k 1/910000/910100/ |p 2 |y j | ||
| 998 | |g 112919017X |a Roider, Tobias |m 112919017X:Roider, Tobias |d 910000 |d 910100 |e 910000PR112919017X |e 910100PR112919017X |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN157189134X |e 3005591301 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"recId":"334374782","pubHistory":["Volume 4, issue 1 (June 1998)-Volume 26, issue 12 (December 2020)"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["334374782"],"issn":["1523-6536"],"zdb":["2057605-5"]},"disp":"Maintenance Rituximab after high-dose therapy and autologous stem cell transplantation in mantle cell lymphomaBiology of blood and marrow transplantation","language":["eng"],"part":{"extent":"2","volume":"23","year":"2017","text":"23(2017), 11, Seite 1811-1812","pages":"1811-1812","issue":"11"},"origin":[{"dateIssuedDisp":"[1998-2020]","publisherPlace":"[Erscheinungsort nicht ermittelbar] ; Charlottesville, Va.","publisher":"Elsevier Health Sciences ; Carden Jennings"}],"note":["Gesehen am 16.03.2021"],"titleAlt":[{"title":"BBMT"}],"title":[{"subtitle":"BBMT ; the official journal of the American Society for Blood and Marrow Transplantation","title_sort":"Biology of blood and marrow transplantation","title":"Biology of blood and marrow transplantation"}],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"id":{"doi":["10.1016/j.bbmt.2017.09.008"],"eki":["157189134X"]},"recId":"157189134X","name":{"displayForm":["Tobias Roider, Sascha Dietrich"]},"physDesc":[{"extent":"2 S."}],"language":["eng"],"origin":[{"dateIssuedDisp":"November 2017","dateIssuedKey":"2017"}],"note":["Gesehen am 10.04.2018"],"title":[{"title_sort":"Maintenance Rituximab after high-dose therapy and autologous stem cell transplantation in mantle cell lymphoma","title":"Maintenance Rituximab after high-dose therapy and autologous stem cell transplantation in mantle cell lymphoma"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"given":"Tobias","role":"aut","family":"Roider","display":"Roider, Tobias"},{"family":"Dietrich","display":"Dietrich, Sascha","role":"aut","given":"Sascha"}]} | ||
| SRT | |a ROIDERTOBIMAINTENANC2017 | ||